Home・Aandelen Lijst・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Gesloten

SectorGezondheidszorg

17.05 -3.51

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.98

Max

17.6

Belangrijke statistieken
By Trading Economics
Inkomsten	9.2M 4.6M
Verkoop	27M 419M
EPS	0.56
Winstmarge	1.103
Werknemers	4,427
EBITDA	-35M 28M

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+9.11% upside

Dividenden
By Acuity
Volgende Winsten	29 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-129M 1.4B
Vorige openingsprijs	20.56
Vorige sluitingsprijs	17.05

Nieuwssentiment

By Acuity

25%

75%

72 / 340 Rangschikking in Healthcare

Integra LifeSciences Holdings Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 aug 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

5 aug 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

4 aug 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

3 aug 2026, 20:51 UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

31 jul 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

30 jul 2026, 17:41 UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

29 jul 2026, 21:01 UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

28 jul 2026, 20:03 UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

27 jul 2026, 19:51 UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

24 jul 2026, 19:02 UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

21 jul 2026, 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 jul 2026, 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Peer Vergelijking

Prijswijziging

Integra LifeSciences Holdings Corp Prognose

Koersdoel

By TipRanks

9.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 19.29 USD 9.11%

Hoogste 25 USD

Laagste 17 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Integra LifeSciences Holdings Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

9 ratings

Buy

Hold

Sell

Gebaseerd op 9 analisten die aandelenratings hebben gegeven aan Integra LifeSciences Holdings Corp - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

72 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.